App for support and networking for people with thalassaemia.
Countries where these languages are spoken.
The ThaliMe app helps people with the rare group of thalassaemic blood disorders to:
The app was developed with the support of the international not-for-profit, non-governmental umbrella organisation, Thalassaemia International Foundation.
“ThaliMe is a much needed innovative mobile program, developed and deployed to greatly aid and improve the lives of people living with thalassaemia…TIF views this innovative approach to patient care and the use of mobile technology for patient empowerment and outreach as a critical component of the overall thalassaemia care…
…ThaliMe also helps to connect the worldwide thalassaemia community members to one another and to those who care for them. Through ThaliMe, patients are linked to private, peer to peer and peer to caregiver support networks to reduce isolation and improve the patients’ sense of support.”
- Thalassaemia International Magazine, Issue 66b, page 30
“Curatio and the Thalassemia International Federation, created a free private mobile social networking app for Thalassemia patients called ThaliMe. This app connects patients with each other through a specific matchmaking process, allowing them to create their own network of Thalassemia patients of their own choosing. There is also a medtracker feature on it with all the Thalassemia medications! Please check it out and share it with your fellow Thalassemia friends.”
PatientView provides this website for use as information, or for educational purposes. We do not warrant that the information we provide on the website will meet your health or medical requirements. Contact a health professional if you are concerned about your health. Nor can we guarantee that the information we provide on the website will always be up to date or accurate. PatientView is providing details of apps recommended by patient groups, an act which does not imply PatientView’s endorsement of any app. PatientView is not responsible for third-party content. Read more for copyright considerations